Crdl stock forecast.

View Cardiol Therapeutics Inc CRDL investment & stock information. Get the latest Cardiol Therapeutics Inc CRDL detailed stock quotes, stock data, Real-Time ECN, charts, stats and...

Crdl stock forecast. Things To Know About Crdl stock forecast.

Cardiol Therapeutics Inc (CRDL) stock is trading at $0.61 as of 3:45 PM on Wednesday, May 17, a rise of $0.01, or 1.33% from the previous closing price of $0.60. The stock has traded between $0.56 and $0.63 so far today. Volume today is less active than usual. So far 56,068 shares have traded compared to average volume of 120,739 shares.Provide the latest market data of Cardiol Therapeutics (CRDL), including prices, candlestick charts of various timeframes, basic information and real-time ...View Cardiol Therapeutics Inc CRDL investment & stock information. Get the latest Cardiol Therapeutics Inc CRDL detailed stock quotes, stock data, Real-Time ECN, charts, stats and...Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...

Cordel Group Plc earnings per share revisions and analysts forecast | London Stock Exchange: CRDL | London Stock Exchange

The average Bank Of America stock price prediction forecasts a potential upside of 14.5% from the current BAC share price of $30.96. What is BAC's forecast return on equity (ROE) for 2023-2026? (NYSE: BAC) forecast ROE is N/A, which is considered weak.Web

Analyst Forecast. The average price target for CRDL is $4.50, which is 423.26% higher than the current price. The consensus rating is "Strong Buy". Price …TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebApr 13, 2022 · Cardiol Therapeutics Inc (CRDL) stock is trading at $1.74 as of 3:43 PM on Wednesday, Apr 13, a rise of $0.06, or 3.56% from the previous closing price of $1.68. The stock has traded between $1.66 and $1.80 so far today. Volume today is more active than usual. Alpine’s stock has gained 62.3% so far this year. In the past 60 days, estimates for Alpine’s 2023 loss per share have narrowed from $1.43 to $1.18, while those for 2024 have improved from a ...

C$-10.90M C$-11.80M C$-9.23M C$-23.56M C$0.00M C$0.00M FCFS: Free Cash Flow Per Share

Find the latest Flora Growth Corp. (FLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.

searchCompare to. Cardiol Therapeutics Inc. $1.26. CRDL 1.61%. AKUMIN INC. $0.43. AKU 0.00%. FSD Pharma Inc. $1.05. HUGE 0.019%. Immunoprecise Antibodies Ltd.Cordel Group's stock was trading at GBX 6.25 on January 1st, 2023. Since then, CRDL shares have decreased by 17.6% and is now trading at GBX 5.15. View the best growth stocks for 2023 here.WebPeople use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Find the latest Charles River Laboratories International, Inc. (CRL) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest Cardiol Therapeutics Inc. (CRDL) stock price, news, historical charts, analyst ratings and financial information from WSJ.

2017. n/a. David Elsley. https://www.cardiolrx.com. Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double ...Based on short-term price targets offered by three analysts, the average price target for Cardiol Therapeutics Inc. comes to $4.50. The forecasts range from a …Find the latest Cardiol Therapeutics Inc. (CRDL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Find the latest Cardiol Therapeutics Inc. (CRDL.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.WebOn average, 1 Wall Street analysts forecast CRDL's revenue for 2027 to be $1,562,922,478, with the lowest CRDL revenue forecast at $1,562,922,478, and the …Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...

Aenza S.A.A. saw a decrease in short interest in October. As of October 31st, there was short interest totaling 11,100 shares, a decrease of 6.7% from the October 15th total of 11,900 shares. Based on an average daily trading volume, of 9,200 shares, the days-to-cover ratio is presently 1.2 days.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Lucid Group share forecasts, stock quote and buy / sell signals below. According to present data Lucid Group's LCID shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Currently there seems to be a trend where stocks in the …

Alpine’s stock has gained 62.3% so far this year. In the past 60 days, estimates for Alpine’s 2023 loss per share have narrowed from $1.43 to $1.18, while those for 2024 have improved from a ...Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.TSX CRDL : Cardiol Therapeutics Inc. stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical AnalysisTipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comWebCardiol Therapeutics Stock Earnings. The value each CRDL share was expected to gain vs. the value that each CRDL share actually gained. Cardiol Therapeutics ( CRDL) reported Q2 2023 earnings per share (EPS) of -$0.09, meeting estimates of -$0.09 by 6.63%. In the same quarter last year, Cardiol Therapeutics 's earnings per share (EPS) was -$0.08.CRDL Cardiol Therapeutics Forecast 2023. Check the latest CRDL quote. Read market charts, analyst ratings and a financial calendar. CRDL Cardiol Therapeutics Forecast 2023. Check the latest CRDL quote. Read market charts, analyst ratings and a financial calendar. more > HOME; TRADING. AI Robots. Stocks & ETFs & FOREX. …

Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Cardiol Therapeutics Inc have a median target of 3.60, with a high estimate of 6.00 and a low estimate of 3.26. The median estimate represents a +308.91% increase from the last price of 0.88.

Cardiol Therapeutics Inc. (CRDL) latest earnings report: revenue, EPS, surprise, history, news and analysis.

Forecast . Price target. 5.88 0.00 0.00%. The 3 analysts offering 1 year price forecasts for CRDL have a max estimate of — and a min estimate of —. Analyst rating. Based on 3 analysts giving stock ratings to CRDL in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreWebCardiol Therapeutics Inc CRDL reported a quarterly adjusted loss of 9 cents per share for the quarter ended in September, higher than the same quarter last year, when the company reported EPS of -13 cents. The lone analyst forecast for the quarter was for a loss of 12 cents per share. Reported revenue was zero ; analysts expected zero.In fact, four respected analysts conclude that CRDL stock will more likely be at least 174% higher on the low estimate, 640% on the high, and 328% in the middle. In other words, at $0.81, CRDL stock is more than a ground-floor opportunity; it's a bargain basement one. Remember, the bullish case isn't wishful thinking.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.According to our analyst's projection, CRDL's Stock Price Forecast for 2023 is $0.8351, 2025 is $6.05, 2030 is $15.50, and $30 in 2040. Cardiol...We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...The average Li Cycle Holdings stock price prediction forecasts a potential upside of 484.05% from the current LICY share price of $0.70. What is LICY's forecast return on equity (ROE) for 2023-2025? (NYSE: LICY) forecast ROE is -11.02%, which is considered weak.The value each CRDL share was expected to gain vs. the value that each CRDL share actually gained.. Cardiol Therapeutics (CRDL) reported Q3 2023 earnings per share (EPS) of-$0.07, beating estimates of -$0.09 by 21.40%.In the same quarter last year, Cardiol Therapeutics's earnings per share (EPS) was-$0.10.Cardiol Therapeutics is expected to …WebAnalyst Future Growth Forecasts. Earnings vs Savings Rate: CRDL is forecast to remain unprofitable over the next 3 years. Earnings vs Market: CRDL is forecast to remain …

Find the latest Flora Growth Corp. (FLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.The average Cardiol Therapeutics stock price prediction forecasts a potential upside of 237.08% from the current CRDL share price of $0.89. What is CRDL's forecast return on equity (ROE) for 2023-2026?The average Agora stock price prediction forecasts a potential upside of 17.65% from the current API share price of $2.72. What is API's forecast return on equity ...Analyst Forecast. According to 2 analysts, the average rating for CRDL stock is "Strong Buy." The 12-month stock price forecast is $4.5, which is an increase of 383.87% from the latest price.Instagram:https://instagram. pdt td ameritradeshare prices lloyds bankiphone 15 price increasecan i retire in canada Average target price for CRDL - Cardiol Therapeutics is predicted at $1.4147 within next 1 yearWebSee Cardiol Therapeutics Inc. (CRDL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. apple paying dividendsh and r block audit protection Dec 27, 2022 · CRDL stock forecasts 2025, with some analysts predicting that the share price may be lower than it is now. If you are new to the field of investment, you should especially evaluate the opinions of experts. According to some experts’ Cardiol stock forecast and some CRDL stock news, the price may drop by about 33%. Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.Web ssbank The forecast for Amazon stock, splits aside, is for steadily increasing price action punctuated by pullbacks, corrections, and consolidations. While there is competition for Amazon, this company is entrenched and will stand the test of time because eCommerce is the way businesses thrive in today's markets. Read More . AMZN Stock Price History. …WebFind the latest Momentus Inc. (MNTS) stock quote, history, news and other vital information to help you with your stock trading and investing.